Understand any stock in simple English
Alkem makes and sells generic medicines and health products for people in India and around the world.
Alkem Laboratories is one of India's biggest makers of generic medicines. A generic drug is a copy of a medicine whose original patent has expired — same active ingredient, same effect, sold far cheaper. Alkem sells these in pill, capsule and injection form under its own brand names, mostly to doctors and pharmacies in India, where it earns the bulk of its money.
The company's home turf is India, but a big chunk of its business comes from the United States, where it sells generic prescription drugs through partners and its own filings. It also makes active pharmaceutical ingredients — the raw chemical powder that goes into a finished pill — and sells nutraceuticals, which are vitamins and health supplements. It has a small biosimilars effort too: near-copies of complex biologic drugs made from living cells. Why do customers pick Alkem over the dozens of other Indian generic makers? Scale and reach. Its sales force visits doctors and chemists across India, and it has built trusted brands in areas like antibiotics, pain relief, and stomach and heart medicines. Being an established name matters in medicine, because a doctor prescribing a familiar brand is the whole game.
The business has real warts. Generic drug prices fall relentlessly as more copies hit the market, and the U.S. market in particular is brutally price-competitive. Regulators like the U.S. Food and Drug Administration inspect factories and can ban shipments if they find problems, a risk every Indian drugmaker faces. Alkem spends heavily on research and on building new plants, and it pays a dividend to shareholders. Its bet is simple: make reliable medicine cheaply at huge volume, and let India's growing health spending do the rest.
Saved answer · last researched 17 Nov 2026